✦ LIBER ✦

A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk

✍ Scribed by Daniele Campa; Katja Butterbach; Susan L. Slager; Christine F. Skibola; Silvia de Sanjosé; Yolanda Benavente; Nikolaus Becker; Lenka Foretova; Marc Maynadie; Pierluigi Cocco; Anthony Staines; Rudolf Kaaks; Paolo Boffetta; Paul Brennan; Lucia Conde; Paige M. Bracci; Neil E. Caporaso; Sara S. Strom; Nicola J. Camp; James R. Cerhan; GEC Consortium; Federico Canzian; Alexandra Nieters

Book ID: 112101602
Publisher: John Wiley and Sons
Year: 2011
Tongue: French
Weight: 450 KB
Volume: 131
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.26436

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comprehensive study of polymorphisms i

A comprehensive study of polymorphisms in ABCB1, ABCC2 and ABCG2 and lung cancer chemotherapy response and prognosis

✍ Daniele Campa; Phillip Müller; Lutz Edler; Lena Knoefel; Roberto Barale; Claus P 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 French ⚖ 429 KB

Characterisation of the roles of ABCB1,

Characterisation of the roles of ABCB1, ABCC1, ABCC2 and ABCG2 in the transport and pharmacokinetics of actinomycin D in vitro and in vivo

✍ Christopher R. Hill; David Jamieson; Huw D. Thomas; Colin D.A. Brown; Alan V. Bo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 988 KB

Gene-wide tagging study of the associati

Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy

✍ Kwan, Patrick; Wong, Virginia; Ng, Ping Wing; Lui, Colin Hiu Tung; Sin, Ngai Chu 📂 Article 📅 2011 🏛 Future Medicine 🌐 English ⚖ 391 KB

Associations of ABCB1, ABCC2, and ABCG2

Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer

✍ Ji-Youn Han; Hyeong-Seok Lim; Yeon-Kyeong Yoo; Eun Soon Shin; Yong Hoon Park; Su 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 215 KB 👁 2 views

## Abstract ## BACKGROUND. The authors investigated whether __ABCB1, ABCC2,__ and __ABCG2__ genetic polymorphisms affect pharmacokinetics (PK) of irinotecan and treatment outcome of patients with advanced nonsmall cell lung cancer (NSCLC). ## METHODS. Blood samples from 107 NSCLC patients treate

Expression of the drug transporters MDR1

Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver

✍ Nadine Albermann; Friedrich Hubertus Schmitz-Winnenthal; Kaspar Z’graggen; Chris 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 374 KB

Erratum: Associations of ABCB1, ABCC2, a

Erratum: Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer

✍ Ji-Youn Han; Hyeong-Seok Lim; Yeon-Kyeong Yoo; Eun Soon Shin; Yong Hoon Park; Su 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB 👁 1 views